Post-transplant lymphoproliferative disorders in renal transplantation: Two decades of experience;Enfermedad linfoproliferativa postrasplante renal. Dos décadas de experiencia

Nefrologia

Volumn 30, Issue 6, 2010, Pages 669-675

  Franco, A ^a   Jimenez L ^a   Sillero, C ^a   Trigueros, M ^a   Gonzalez D ^a   Alcaraz, E ^a   Olivares, J ^a  

^a HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

Author keywords

Epstein Barr virus; Post transplant lymphoproliferative disorder; Renal transplantation

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; B LYMPHOCYTE; CADAVER; DISEASE TRANSMISSION; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; FEMALE; FOLLOW UP; HUMAN; IMMUNOCOMPROMISED PATIENT; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; ISOLATION AND PURIFICATION; KIDNEY TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; MALE; MIDDLE AGED; PATHOLOGY; POSTOPERATIVE COMPLICATION; RISK FACTOR; SPAIN; VIROLOGY; VIRUS ACTIVATION;

ADOLESCENT; ADULT; AGED; B-LYMPHOCYTES; CADAVER; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; FOLLOW-UP STUDIES; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSION; INCIDENCE; KIDNEY TRANSPLANTATION; LYMPHOPROLIFERATIVE DISORDERS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; SPAIN; VIRUS ACTIVATION; YOUNG ADULT;

EID: 78649930167     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: 10.3265/Nefrologia.pre2010.Aug.10361     Document Type: Article

References (18)

1. Payá CV, Fung JJ, Nalesnik MA, Kieff F, Green M, Gores G, et al. Meeting on Epstein-Barr virus induce post-transplant lymphoproliferative disorder. Transplantation 1999;68:1517-25.
2. Leblond V, Davi F, Charlotte F, Dorent R, Bitker MO, Sutton L, et al. Post-transplant lymphoproliferative disorder not associated with Epstein-Barr virus: A distint entity? Clin Oncol 1998;16:2052-9.
3. Rosselet A, Vu DH, Meylan P, Baur Chauber AS, Schapira M, Pascual M, et al. Associations of Serum EBV DNA and gammopathy with Post-transplant lymphoproliferative disorder. Clin Transplant 2009;23:74-82.
4. Ghobrial, IM, Habermann TM, Macon WR, Ristow KM, Larson TS, Walker RC, et al. Differences between early and late post-transplant lymphoproliferative disorders in solid organ transplant patients: are they two different disesase. Transplantation 2005;79:244-7.
5. Sánchez Fructuoso A. Enfermedad linfoproliferativa postrasplante asociada a virus de Epstein-Barr. Nefrologia 2005;25:20-30.
6. Van Leeuwen MT, Grulich AE, Webster AC, Mc Credie MRE, Stewart JH, Mc Donald SP, et al. Immunosuppression and other risk factors for early and late non-Hodgkin lymphoma after kidney transplantation. Blood 2009;114:630-7.
7. Callard S, Dharnidharka V, Agodoa L, Bohend E, Abbott K. Post-transplant lymphoproliferative disorder after renal transplantation in the United States in Era of modern immunosuppression. Transplantation 2005;80:1233-43.
8. Opelz G, Döhler B. Lymphomas after solid organ transplantation: A Collaborative transplant study report. Am J Transplant 2003;4:222-30.
9. Opelz G, Daniel V, Naujokat C, Döhler B. Epidemiology of pretransplant EBV and CMV serostatus in relation to posttransplant non-Hodgkin lymphoma. Transplantation 2009;88:962-7.
10. Mañez R, Breining MC, Linden P, Wilson J, Torres-Cisneros JU, Kusnei S, et al. Post-transplant lymphoproliferative disease in primary Epstein Barr Virus Infection after liver transplantation: The role of Cytomegalovirus disease. J Infect Dis 1997;176:1462-7.
11. Opelz G, Döhler B. Impact of HLA mismatching on incidence of posttransplant non-Hodkin lymphoma after kidney transplantation. Transplantation 2010;89:567-72.
12. Swerdlow SH. International agency for research on cancer, World Health Organization. WHO Classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon, France: International Agency for Research on Cancer, 2008.
13. Smith JM, Rudser K, Gillend Kestenbaum, B, Seliger S, Weiss N, Mc Donald RA, et al. Risk of lymphoma after renal transplantation varies with time: An analysis of the United States Renal Data System. Transplantation 2006;81:175-80.
14. Morgans AK, Reshef R, Tsai DE. Post-transplant lymphoproliferative disorder following kidney transplant. Am Kidney Dis 2010;55:168-80.
15. Trappe R, Hinrichs C, Appel U, Babel N, Reinke P, Neumayer HH, et al. Treatment of PTLD with Rituximab and CHOP reduces the risk of renal graft impairment after reduction of immunosuppression. Am J Transplant 2009;9:2331-7.
16. Pascual J. Post-transplant lymphoproliferative disorder. The potential of proliferation signal inhibitors. Nephrol Dial Transplant 2007;22:27-35.
17. Saadat A, Einollahi B, Ahmadzad-Asi MA, Moradi M, Nafar M, Pourfarziani V, et al. Post-transplant lymphoproliferative disorder in renal transplant recipients: Report of over 20 years of experience. Transplant Proc 2007;39:1071-3.
18. Franco A, Jiménez L, Aranda I, Álvarez L, González M, Rocamora N, et al. La Enfermedad linfoproliferativa difusa postrasplante renal y su relación con el virus Epstein-Barr. Experiencia de un Centro. Nefrologia 2002;22:463-9.